How to explain the reduced cardiovascular mortality in the ticagrelor arm of the PLATO trial?

International Journal of Cardiology

Volumn 149, Issue 2, 2011, Pages 265-267

  De Servi, Stefano ^a   Savonitto, Stefano ^b  

^a Ospedale Civile di Legnano   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Acute coronary syndromes; Clopidogrel; Prasugrel; Ticagrelor

Indexed keywords

ADENOSINE RECEPTOR; CLOPIDOGREL; PRASUGREL; PURINERGIC P2Y12 RECEPTOR; TICAGRELOR;

ACUTE CORONARY SYNDROME; BLEEDING; BLOOD CLOT LYSIS; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL (TOPIC); CONSERVATIVE TREATMENT; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; HEART INFARCTION; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; HUMAN; LETTER; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; UPREGULATION;

EID: 79957514069     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.02.051     Document Type: Article

References (12)

1. L. Wallentin, R.C. Becker, and A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
2. S.D. Wiviott, E. Braunwald, and C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
3. P.G. Steg, S. James, and R.A. Harrington Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention a platelet inhibition and patient outcomes (PLATO) trial subgroup analysis Circulation 122 2010 2131 2141
4. G. Montalescot, S. Wiviott, E. Braunwald, S.A. Murphy, C.M. Gibson, and C.H. McCabe Prasugrel compared to clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial Lancet 373 2009 723 731
5. A.A.C.M. Heestermans, J.W. van Werkum, and D. Taubert Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction Thromb Res 122 2008 776 781
6. C.P. Cannon, R.A. Harrington, and S. James Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study Lancet 375 2010 283 293
7. S. James, M.T. Roe, and C.P. Cannon Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for a non-invasive management in the PLATO trial Eur Heart J 31 2010 203 (Abstract Supplement)
8. C.T. Chin, M.T. Roe, and K.A. Fox Design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY managed Acute Coronary Syndromes (TRILOGY ACS) trial Am Heart J 160 2010 16 22e
9. C. Held, N. Asenblad, and J.P. Bassand Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO trial J Am Coll Cardiol 57 2011 (published online Dec 29, 2010)
10. P.K. Smith, G.J. Despotis, and L.T. Goodnough Mortality benefit with prasugrel in TRITON-TIMI 38 Coronary Artery Bypass Grafting (CABG) cohort: risk adjusted retrospective data analysis Abstract 10881, presented at the AHA Scientific sessions 2010, Chicago, IL November 2010
11. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150
12. L.G. Shewan, and A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2